3 unknown, 1 completed, 1 recruiting. 4 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Unknown 3, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Rupert Lanzenberger: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Stress on Brain Energy Metabolism Montreal Imaging Stress Test - Stress | Not applicable | Recruiting | Rupert Lanzenberger | 68 | 2024-03-01 | 2025-12-23 |
| Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI 56mg esketamine (2x Spravato® 28 mg nasal spray), 0.9% saline solution nasal spray - Ketamine Treatment | Phase 1 | Completed | Rupert Lanzenberger | 33 | 2022-06-01 | 2024-04-15 |
| TBS in Major Depression theta-burst stimulation (TBS) using a MagPro X1000 - Treatment Resistant Depression | Not applicable | Unknown | Rupert Lanzenberger | 80 | 2017-08-01 | 2019-03-13 |
| Simultaneous PET/MR Imaging of Human Brain Plasticity Tetris - Neuronal Plasticity | Not applicable | Unknown | Rupert Lanzenberger | 40 | 2017-05-01 | 2019-09-23 |
| Effects of TBS on 5-HT1A Receptor Binding theta-burst stimulation using a MagPro X1000, sham stimulation using a MagPro X1000 - Treatment Resistant Depression | Not applicable | Unknown | Rupert Lanzenberger | 80 | 2016-12-01 | 2018-08-16 |
Depressive Disorder, Treatment-Resistant (2)
Transcranial Magnetic Stimulation (2) · Esketamine (1) · Nasal Sprays (1)
Austria (5)
Andreas Hahn, Assoc.Prof. (1) · Siegfried Kasper, MD (1)